Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Selective arterial embolization of renal angiomyolipomas: A 10-year experience

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. Open vs robot-assisted radical cystectomy (BORARC): a double-blinded, randomised feasibility study

    Research output: Contribution to journalJournal articlepeer-review

  2. Reply by Authors

    Research output: Contribution to journalComment/debatepeer-review

View graph of relations

Objectives: To study safety and efficacy of selective endovascular trans-arterial embolization (TAE) of renal angiomyolipoma (AML) in a 10-year period at a regional tertiary referral center in Denmark.

Patients and methods: All 56 patients who underwent TAE of renal AML at Departments of Urology and Radiology, Copenhagen University Hospital - Rigshospitalet, Denmark, from 2009 to 2020 were included. Seven without preoperative and postoperative imaging were excluded, leaving 49 patients for analysis. From national electronic medical records, we retrieved patient characteristics, surgical data, and follow-up data. Tumor size at the time of embolization and during follow-up was compared using Student's paired t test. Estimated glomerular filtration rate (eGFR) pre- and post-embolization were compared using Wilcoxon rank sum test.

Results: We included 49 patients of whom 4 had two tumors treated in the same TAE procedure. Median age was 50 years (interquartile range [IQR]: [29-67 years]), and the median follow-up time was 4.6 years [IQR: 3.0-6.7 years]. Post-embolization syndrome (PES) was experienced in 27 patients, and non-PES in 5 patients. Median length of hospital stay was 0 days [IQR, 0-1]. Postoperative Everolimus immunosuppressive treatment was offered to seven patients. Median tumor size was 6.0 cm [IQR: 4.6-7.9 cm] and was significantly reduced to 3.7 cm [IQR: 2.5-5.2 cm] after treatment (p < 0.001). Kidney function was not affected by TAE. Three deaths, not related to AML, were noted during follow-up.

Conclusion: Embolization of AML was in this cohort effective to significantly reduce tumor size without serious adverse events and loss of renal function. TAE is a safe and efficacious treatment and the preferred minimally invasive treatment option of AML.

Original languageEnglish
JournalBJUI compass
Volume3
Issue number1
Pages (from-to)86-92
Number of pages7
ISSN2688-4526
DOIs
Publication statusPublished - Jan 2022

Bibliographical note

© 2021 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.

ID: 77849245